"Spreisel" (dasatinib): price, analogues. Where to Buy a Sprice
The drug "Sprysel" oncologists is prescribed to patients with chronic myelogenous leukemia and acute lymphoblastic leukemia. This drug belongs to the group of protein kinase inhibitors.
"Spriceil" reviews are positive. Doctors and patients note the high effectiveness of the drug, but many complain about the high cost. So, in Moscow pharmacies on "Spriceil" the price was fixed within the range from 98 000 to 192 000. The difference is due to differences in dosage. Treatment with the help of such a tool by far not everyone, and yet the way out is.
Generic of the drug
Despite the fact that the original "Sprites"the price to many patients may seem completely unaffordable, one should not despair. There is a generic drug, the cost of which is several times lower.
Generic is a drug that comes withusing the same formulation as the original remedy. In addition, it has a similar high efficiency. Then why is the generic cheaper? This is because, in its production, the issuing company does not develop a pharmacological formula on its own. She also does not conduct clinical trials (they have already been carried out by a firm that launched the original) and does not develop an advertising campaign. As a result, many patients have the opportunity to purchase life-saving drugs at an affordable price.
Where to buy "Sprite" cheaper
If you or your loved ones are treated with myeloleukemia, the doctor recommended using the drug we are considering, contact the Internet resource. Here you can order "Sprite" from the manufacturer from India.
Before you leave an application for the purchase of the drug, prepare documents confirming the need for treatment with this particular remedy. This is required by site rules.
Sprisel: instructions for use
Tablets are recommended to be swallowed whole, without chewing, with water. Take the medication once a day - in the morning or in the evening.
The initial recommended dose for patients withchronic myeloid leukemia - 100 mg. In other cases, the dosage increases to 140 mg. However, remember that appoint a drug and choose the right dosage should only be a doctor.
"Sprysel" can not be prescribed to all patients with myeloid leukemia. It is not recommended for use in the treatment of the following categories of patients:
- pregnant and lactating women;
- children and adolescents;
- with an individual intolerance of the main active substance - dasatinib.
For hepatic insufficiency, the drug should be administered with caution.
Possible side effects
Taking the drug can cause:
- upper respiratory tract infection;
- fluid retention in the body;
- pain in the digestive tract;
- skin rash;
- shortness of breath;
If these symptoms occur, the attending physician can adjust the dosage of the remedy.